Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection (Q34384793)

1 August 2017

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection (English)

1 reference

1 August 2017

14

Jürgen Rockstroh

1 reference

Markus Peck-Radosavljevic

1 August 2017

13

object named as

Markus Peck-Radosavljevic

0 references

Robert Flisiak

11

object named as

Robert Flisiak

1 reference

1 August 2017

9

Michael P Manns

1 reference

1 August 2017

12

Heiner Wedemeyer

1 reference

1 August 2017

1

Jerzy Jaroszewicz

1 reference

1 August 2017

15

Markus Cornberg

1 reference

1 August 2017

Thomas Reiberger

2

1 reference

1 August 2017

Dirk Meyer-Olson

3

1 reference

1 August 2017

Stefan Mauss

4

1 reference

1 August 2017

Martin Vogel

5

1 reference

1 August 2017

Patrick Ingiliz

6

1 reference

1 August 2017

Berit Anna Payer

7

1 reference

1 August 2017

Matthias Stoll

8

1 reference

1 August 2017

Reinhold E Schmidt

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

15 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

8

1 reference

1 August 2017

e43143

1 reference

Creative Commons Attribution 4.0 International

1 August 2017

start time

15 August 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Epidemiology of viral hepatitis and HIV co-infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419648

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22905219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of chronic hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22905219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22905219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0043143

1 reference

1 August 2017

0 references

1 reference

1 August 2017

1 reference